Literature DB >> 22513199

Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab.

H Lee, S H Park, S K Kim, J Y Choe, J S Park.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22513199

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  6 in total

Review 1.  Inflammatory Joint Disorders and Neutrophilic Dermatoses: a Comprehensive Review.

Authors:  Massimo Cugno; Roberta Gualtierotti; Pier Luigi Meroni; Angelo Valerio Marzano
Journal:  Clin Rev Allergy Immunol       Date:  2018-04       Impact factor: 8.667

Review 2.  A Comprehensive Review of Neutrophilic Diseases.

Authors:  Angelo V Marzano; Alessandro Borghi; Daniel Wallach; Massimo Cugno
Journal:  Clin Rev Allergy Immunol       Date:  2018-02       Impact factor: 8.667

Review 3.  IL-1 blockade in autoinflammatory syndromes.

Authors:  Adriana A Jesus; Raphaela Goldbach-Mansky
Journal:  Annu Rev Med       Date:  2014       Impact factor: 13.739

Review 4.  Biological treatments: new weapons in the management of monogenic autoinflammatory disorders.

Authors:  Antonio Vitale; Donato Rigante; Orso Maria Lucherini; Francesco Caso; Isabella Muscari; Flora Magnotti; Maria Giuseppina Brizi; Susanna Guerrini; Maria Patti; Leonardo Punzi; Mauro Galeazzi; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2013-07-21       Impact factor: 4.711

5.  Case Report: Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne: A Single-Center Experience and Literature Review.

Authors:  Yumei Wang; Na Wu; Keyi Yu; Min Shen
Journal:  Front Immunol       Date:  2021-10-22       Impact factor: 7.561

Review 6.  PSTPIP1-associated myeloid-related proteinaemia inflammatory (PAMI) syndrome; a case presenting as a perinatal event with early central nervous system involvement?

Authors:  Bethany Gillies Whiteside; Hannah Titheradge; Eslam Al-Abadi
Journal:  Pediatr Rheumatol Online J       Date:  2022-07-15       Impact factor: 3.413

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.